Deze website is uitsluitend voorbehouden aan beroepsbeoefenaren in Nederland.

Campus
  1. Artikel
  2. Bron: Campus Sanofi
  3. 3 dec 2024

When to suspect TTP?

Auteur: Sanofi

Editorial Team

TTP is rare and presents similarly to other thrombotic microangiopathies (TMAs), making it difficult to diagnose.

aTTP is a medical emergency: diagnosing aTTP rapidly is critical and can save a life1

When a patient presents with:1

hemolytic-anemia

Severe thrombocytopenia
(often platelets <30 × 109/L)

diagnosing-severe-thrombo

Microangiopathic hemolytic anemia (MAHA)
characterized by the presence of schistocytes in blood smear

icon

With no identified cause

arrow

Text block hide

Why TTP can be difficult to diagnose?

TTP is rare and presents similarly to other thrombotic microangiopathies (TMAs), making it a challenge to diagnose. All TMAs result in thrombosis of capillaries and arterioles due to endothelial injury.2,3

Suspect aTTP_how to diagnose

*STEC-HUS – Hemolytic Uremic Syndrome mediated by E. coli producing Shiga-type toxin or verotoxin;
HUS: Hemolytic Uremic Syndrome
Adapted from Kremer Hovinga et al. Nat Rev Dis Primers 20176

Tests and expected results in patients with suspected aTTP1

Diagnosis of TTP

Dr Marie Scully shares details on how to make a prompt differential diagnosis of TTP.

Neem contact op

Get in touch - dupixent
Wij staan klaar

Heeft u vragen of wilt u meer weten? Wij zorgen dat u zo snel mogelijk geholpen wordt.

Referenties

  1. Scully M, et al. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol. 2012;158(3):323–35.

  2. Arnold DM, Patriquin CJ, Nazy I. Thrombotic microangiopathies: a general approach to diagnosis and management. CMAJ. 2017;189(4):E153-E159. doi:10.1503/cmaj.160142

  3. Tsai H-M. Pathophysiology of thrombotic thrombocytopenic purpura. Int J Hematol. 2010;91(1):1-19. doi:10.1007/s12185-009-0476-1

  4. Tsai H-M, et al. Antibodies to von Willebrand Factor-cleaving protease in acute thrombotic thrombocytopenic purpura.N Engl J Med. 1998;339:1585–94.

  5. Furlan M, et al. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood. 1997;89: 3097–103.

  6. Kremer Hovinga JA, et al. Thrombotic thrombocytopenic purpura. Nat Rev Dis Primers. 2017;3:17020.

MAT-BE-2401121 - 1.0 - 12/2024  

Gerelateerd